ES2106763T3 - Un subgrupo de celulas progenitoras humanas. - Google Patents

Un subgrupo de celulas progenitoras humanas.

Info

Publication number
ES2106763T3
ES2106763T3 ES91303960T ES91303960T ES2106763T3 ES 2106763 T3 ES2106763 T3 ES 2106763T3 ES 91303960 T ES91303960 T ES 91303960T ES 91303960 T ES91303960 T ES 91303960T ES 2106763 T3 ES2106763 T3 ES 2106763T3
Authority
ES
Spain
Prior art keywords
cells
human
subgroup
progenital
progenital cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91303960T
Other languages
English (en)
Inventor
Leon Terstappen
Michael Loken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Application granted granted Critical
Publication of ES2106763T3 publication Critical patent/ES2106763T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE RECLAMA UNA POBLACION SUSTANCIALMENTE PURA DE CELULAS RADICALES DE PROGENITOR HUMANO QUE CARECEN DE CD38 PERO EXPRESAN CD34. ESTAS CELULAS RADICALES SON PLURIPOTENTES Y PUEDEN FORMAR UNA COLONIA DE BLASTO. ESTAS CELULAS PUEDEN UTILIZARSE EN TRANSPLANTES DEL TUETANO OSEO Y TERAPIA DE GENES.
ES91303960T 1990-05-01 1991-05-01 Un subgrupo de celulas progenitoras humanas. Expired - Lifetime ES2106763T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51710190A 1990-05-01 1990-05-01

Publications (1)

Publication Number Publication Date
ES2106763T3 true ES2106763T3 (es) 1997-11-16

Family

ID=24058370

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91303960T Expired - Lifetime ES2106763T3 (es) 1990-05-01 1991-05-01 Un subgrupo de celulas progenitoras humanas.

Country Status (11)

Country Link
US (2) US5622853A (es)
EP (1) EP0455482B1 (es)
JP (1) JP3070865B2 (es)
AT (1) ATE157119T1 (es)
AU (1) AU641230B2 (es)
CA (1) CA2041258A1 (es)
DE (1) DE69127313T2 (es)
DK (1) DK0455482T3 (es)
ES (1) ES2106763T3 (es)
GR (1) GR3024783T3 (es)
IE (1) IE911145A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571714A (en) 1988-12-22 1996-11-05 Celtrix Pharmaceuticals, Inc. Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
US5605822A (en) * 1989-06-15 1997-02-25 The Regents Of The University Of Michigan Methods, compositions and devices for growing human hematopoietic cells
US5635386A (en) 1989-06-15 1997-06-03 The Regents Of The University Of Michigan Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5635387A (en) * 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5840580A (en) * 1990-05-01 1998-11-24 Becton Dickinson And Company Phenotypic characterization of the hematopoietic stem cell
DE69232682T2 (de) * 1991-10-23 2003-03-13 Nexell Therapeutics Inc., Irvine Verfahren zur selektiven vermehrung von cd34 positiven zellen
US6004807A (en) * 1992-03-30 1999-12-21 Schering Corporation In vitro generation of human dendritic cells
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
US5436151A (en) * 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US5460964A (en) * 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
EP0670735B1 (en) * 1992-11-13 1997-04-02 Board Of Regents Of The University Of Washington Peripheralization of hematopoietic stem cells
WO1994011493A1 (en) * 1992-11-16 1994-05-26 Applied Immune Sciences, Inc. Pluripotential quiescent stem cell population
EP0684828A4 (en) * 1993-02-19 1996-08-07 Celtrix Pharma PROPAGATION OF STEM CELLS IN LONG-TERM CULTURES OF BONE MARBLE CELLS BY REALIZING T6F-BETA.
EP0697880B1 (en) * 1993-05-03 2001-08-22 Genentech, Inc. Inhibition of leukocyte adhesion
US6555324B1 (en) * 1993-11-04 2003-04-29 Becton Dickinson & Company Method to distinguish hematopoietic progenitor cells
EP0662512A3 (en) * 1993-12-20 1997-01-15 Becton Dickinson Co Human hematopoietic stem cells.
US5972703A (en) 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
DE69531432T2 (de) * 1994-09-23 2004-07-29 Becton Dickinson And Co. Verfahren zur Unterscheidung von granulomoncytischen Progenitoren in einer Population von CD34+ Zellen
US5874266A (en) * 1997-03-27 1999-02-23 Palsson; Bernhard O. Targeted system for removing tumor cells from cell populations
US6340569B1 (en) 1997-11-12 2002-01-22 University Of Pittsburgh Monoclonal antibody and antigens specific therefor and methods of using same
US20020034819A1 (en) 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
CN102008503B (zh) 2001-12-07 2018-10-09 阿斯特利亚斯生物治疗股份公司 人胚胎干细胞衍生的造血细胞
US7799324B2 (en) 2001-12-07 2010-09-21 Geron Corporation Using undifferentiated embryonic stem cells to control the immune system
CA2471392A1 (en) * 2001-12-22 2003-08-21 4-Antibody Ag Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
US7595148B2 (en) 2003-01-25 2009-09-29 Irm Llc Methods and compositions for modulating T lymphocytes
AU2004227205B2 (en) * 2003-04-08 2010-06-10 Yeda Research And Development Co. Ltd Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
CA2544252A1 (en) 2003-11-04 2005-05-26 U.S. Department Of Veterans Affairs Stem cell culture medium and method of using said medium and the cells
EP1851308B1 (en) * 2005-02-02 2013-08-21 NewSouth Innovations Pty Limited Cd4+ cd25+ t-cells activated to a specific antigen
MY154677A (en) 2006-03-07 2015-07-15 Shroff Geeta Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
EP2052076A4 (en) 2006-08-02 2010-07-14 Newsouth Innovations Pty Ltd METHOD FOR IDENTIFYING ANY ANTIGEN-ACTIVATED, CD8-EXPRESSING CD4 + CD25 + T-CELLS
WO2010068812A1 (en) * 2008-12-10 2010-06-17 Abqmr, Inc. Nuclear magnetic resonance apparatus, methods and associated technology
US20120177618A1 (en) * 2009-07-14 2012-07-12 Massachusetts Institute Of Technology Hematopoietic stromal progenitor cells and uses thereof
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US9663008B2 (en) 2012-08-07 2017-05-30 Ts Tech Co., Ltd. Attachment structure for members and vehicle seat
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
EP3613859A1 (en) * 2013-10-24 2020-02-26 Ospedale San Raffaele S.r.l. Method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680383A (en) * 1979-03-20 1987-07-14 Ortho Pharmaceutical Monoclonal antibody to human T cells
US4803262A (en) * 1979-10-09 1989-02-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
US4624925A (en) * 1979-12-04 1986-11-25 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods
US4798806A (en) * 1980-01-08 1989-01-17 Ortho Pharmaceutical Corporation Compositions and methods using a monoclonal antibody to a human T cell antigen
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US4845653A (en) * 1987-05-07 1989-07-04 Becton, Dickinson And Company Method of displaying multi-parameter data sets to aid in the analysis of data characteristics
EP0317156B2 (en) * 1987-11-09 1997-11-12 Becton, Dickinson and Company Method for analysis of hematopoietic cells in a sample
US4987086A (en) * 1987-11-30 1991-01-22 Becton, Dickinson And Company Method for analysis of subpopulations of cells
WO1989008114A1 (en) * 1988-02-25 1989-09-08 The General Hospital Corporation Rapid immunoselection cloning method
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition
US5047321A (en) * 1988-06-15 1991-09-10 Becton Dickinson & Co. Method for analysis of cellular components of a fluid
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell

Also Published As

Publication number Publication date
US5583033A (en) 1996-12-10
DE69127313D1 (de) 1997-09-25
EP0455482A3 (en) 1992-09-02
JPH0576354A (ja) 1993-03-30
JP3070865B2 (ja) 2000-07-31
ATE157119T1 (de) 1997-09-15
AU7429391A (en) 1991-11-07
IE911145A1 (en) 1991-11-06
US5622853A (en) 1997-04-22
DE69127313T2 (de) 1998-01-22
GR3024783T3 (en) 1998-01-30
EP0455482A2 (en) 1991-11-06
EP0455482B1 (en) 1997-08-20
AU641230B2 (en) 1993-09-16
DK0455482T3 (da) 1998-04-06
CA2041258A1 (en) 1991-11-02

Similar Documents

Publication Publication Date Title
ES2106763T3 (es) Un subgrupo de celulas progenitoras humanas.
PT1084230E (pt) Regulação da diferenciação de células estaminais hematopoiéticas através da utilização de células estaminais mesenquimatosas humanas
ATE296875T1 (de) Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen
Đokić et al. Characterization and immunosuppressive properties of mesenchymal stem cells from periapical lesions
JP2002517227A5 (ja) 造血幹細胞を試験管内で維持する方法と組成物
EP2048228B8 (en) Human liver progenitors
TR200200897T2 (tr) Melez matrisler ve melez matriks karışımları
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
YU46723B (sh) Ekspresija, prerada i sekrecija heterologog proteina pomoću kvasca
MY119132A (en) Protein delivery by gene therapy
LV12085A (lv) Dendritiskas sunas stimulejosais faktors
EP0879056A4 (en) MODALATION OF TH1 / TH2 CYTOKINE EXPRESSION BY RIBAVIRIN-M (3) AND RIBAVIRIN (M3) ANALOGS IN ACTIVATED T-LYMPHOZYTES
DK0843731T3 (da) Adenovirusvektorer til genterapi
Arase et al. Culture of human outer root sheath cells from plucked hair follicles in serum-free conditions
AU4299696A (en) Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
Sato et al. Emergence of osteoblast-like cells in a neoplastic human salivary cancer cell line after treatment with 22-oxa-1α, 25-dihydroxyvitamin D3
SU683733A1 (ru) Материал дл изготовлени зубных протезов
IT1244529B (it) Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1
HUP0500106A2 (hu) Egy ABCG-családba tartozó féltranszporter-fehérje alkalmazása sejtek szelektálására és génterápiára
AU4216599A (en) Hematopoietic progenitor cell gene transduction

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 455482

Country of ref document: ES